P&G nabs Nioxin
This article was originally published in The Rose Sheet
Executive SummaryWith purchase of Nioxin Research Laboratories, announced Sept. 3, P&G gains range of innovative professional hair-care products that focus on the scalp to improve appearance of thinning hair, firm says. Nioxin offerings currently are distributed through salons and salon stores in more than 40 countries, P&G says. Acquisition is in harmony with P&G's strategy of focusing on "faster growing, higher margin and more asset-efficient businesses," according to release. The personal care giant will keep Nioxin's brand portfolio, organization and distribution network in place in order to strengthen its commitment to growth in professional salon channel; Brian Graham will stay on as CEO of Nioxin, P&G notes. "This acquisition is a great strategic fit given P&G's leadership and proven strength in its retail scalp care business. Further, P&G's global scale creates opportunities to further grow the Nioxin brand in key markets around the world," says Robert Jongstra, president, P&G Professional Care
You may also be interested in...
NeuClone has reported that its NeuCeptin proposed biosimilar trastuzumab has successfully met all primary and secondary endpoints in a Phase I clinical trial.
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.